Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
BIND Therapeutics

BIND Therapeutics

A nanomedicine company that develops Accurins for targeted therapeutics

OverviewStructured DataIssuesContributorsActivity
Is a
Company
Company
Organization
Organization
Acquisition Transaction
‌
Acquisition of BIND Therapeutics by Pfizer
‌
BIND Therapeutics acquired by Pfizer
AngelList URL
angel.co/bind-therapeutics
B2X
B2B
B2B
CEO
Noubar Afeyan
Noubar Afeyan
CIK Number
1,385,228
Company Operating Status
Active
Competitors
DR Systems
DR Systems
Crunchbase URL
crunchbase.com/organiz...apeutics
Facebook URL
@BINDTHERA
Founded Date
2006
Founder
Noubar Afeyan
Noubar Afeyan
Robert Langer
Robert Langer
Full Address
325 Vassar St Cambridge​, MA, 02139-4818 United States
Headquarters
Massachusetts
Massachusetts
Industry
Biology
Biology
Healthcare
Healthcare
Biotechnology
Biotechnology
Technology
Technology
Investors
RUSNANO Capital
RUSNANO Capital
Polaris Partners
Polaris Partners
ARCH Venture Partners
ARCH Venture Partners
Flagship Pioneering
Flagship Pioneering
Endeavour Vision
Endeavour Vision
NanoDimension
NanoDimension
Rusnano
Rusnano
Latest Funding Round Date
February 2013
Latest Funding Type
Series D
Series D
LinkedIn URL
@company/bind-therapeutics
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
Number of Employees (Ranges)
1 – 10
0
Patents Assigned (Count)
27
Pitchbook URL
pitchbook.com/profiles.../42480-37
Place of Incorporation
Delaware
Delaware
SIC Code
2,834
Exchange
Nasdaq
Nasdaq
Stock Symbol
BIND
Total Funding Amount (USD)
69,900,000
Twitter URL
@BINDTx
Official Website
bindtherapeutics.com
Wellfound ID
bind-therapeutics

Find more companies like BIND Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo